Skip to main content
BrainCited

Mô tả

Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores.

Figure 5

Chart

Source Paper

The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.

Evidence-based complementary and alternative medicine : eCAM (2011)

PMID: 19622601

DOI: 10.1093/ecam/nep063

Cite This Figure

![Figure 5: Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores.]()

> Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." *Evidence-based complementary and alternative medicine : eCAM*, 2011. PMID: [19622601](https://pubmed.ncbi.nlm.nih.gov/19622601/)
<figure>
  <img src="" alt="Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores." />
  <figcaption>Figure 5. Experimental evidence from animal models of neuroimmune disorders showing the effects of specific CAM therapies on Th17 cell frequency and disease severity scores.<br>  Source: Aristo Vojdani et al. "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II.." <em>Evidence-based complementary and alternative medicine : eCAM</em>, 2011. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/19622601/">19622601</a></figcaption>
</figure>